Table of Contents:

1 Report Prologue
2 Introduction
2.1 Introduction
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.1.1 Growing Cases of Spinal Injuries
4.1.2 Growing awareness of spinal non-fusion procedures
4.1.3 Growing Adoption of Sedentary Lifestyle
4.1.4 Growing Prevalence of Obese Population Affecting Spinal Injuries
4.2 Restrains
4.2.1 Treatment Cost
4.2.2 Ethical and Social Concerns
4.2.3 Complications Involved
4.3 Opportunities
4.3.1 Development of New Alternative Treatment Method
4.3.2 Botulinum-A Toxin Injections for Treatment Spinal Cord Injuries
4.3.3 Stem Cell Method in the Treatment in Spinal Injuries
5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Introduction
5.1.2 Bargaining Power of Suppliers
5.1.3 Bargaining Power of Buyers
5.1.4 Threat of New Entrants
5.1.5 Threat of Substitutes
5.1.6 Intensity of Rivalry
?
5.2 Value Chain Analysis
5.2.1 Introduction
5.2.2 Primary Activities
5.2.3 Secondary Activities
6 Global Slip disc market by Types
6.1 Introduction
6.2 Thoracic Herniated Discs
6.3 Lumbar Herniated Disc
6.4 Cervical Herniated Discs
7 Global Slip Disc Market, By Diagnosis
7.1 Introduction
7.2 Physical Examination
7.3 Nerve Conduction Test
7.4 Imaging Tests
8 Global Slip Disc Market, By Treatment
8.1 Introduction
8.2 Medications
8.3 Therapy
8.4 Surgery
9 Global Slip Disc Market, By Regions
9.1 Introduction
9.2 Americas
9.2.1 Americas
9.2.1.1 US
9.2.2 Canada
9.2.3 Latin America
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Australia
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive landscape
10.1 Introduction
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financial Updates
11.1.4 Key Developments
11.2 TEVA Pharmaceutical LTD.
11.2.1 Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financials
11.2.4 Key Developments
11.3 GlaxoSmithKline plc.
11.3.1 Company Overview
11.3.2 Product overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 DePuy Synthes Companies (Part of Johnson & Johnson Services, Inc.)
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Key Developments
11.4.4 Financials
11.4.5 SWOT Analysis
11.5 NuVasive, Inc.
11.5.1 Overview
11.5.2 Product Overview
11.5.3 Financials
11.5.4 Key Developments
11.6 Captiva Spine, Inc.
11.6.1 Overview
11.6.2 Product Overview
11.6.3 Financials
11.6.4 Key Development
?
11.7 Globus Medical, Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments